<!DOCTYPE html><html><head><title> Pacifica Code Section 31A-46-S302 </title><link rel="stylesheet" href="/assets/style.css"/></head><body>
<b><i>
                      Effective 5/12/2020</i></b>
<br>
<b>31A-46-302.&nbsp;
          </b><b>Direct or indirect remuneration by pharmacy benefit managers -- Disclosure of customer costs -- Limit on customer payment for prescription drugs.</b>
<br>
<a id="31A-46-302(1)" name="31A-46-302(1)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(1)</td><td style="width:99%">
If a pharmacy service entity engages in direct or indirect remuneration with a pharmacy, the pharmacy service entity shall make a reimbursement report available to the pharmacy upon the pharmacy's request.</td>
</tr>
</tbody></table>
<a id="31A-46-302(2)" name="31A-46-302(2)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(2)</td><td style="width:99%">
For the reimbursement report described in Subsection <a href="#31A-46-302(1)">(1)</a>, the pharmacy service entity shall:
<a id="31A-46-302(2)(a)" name="31A-46-302(2)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
include the adjusted compensation amount related to a claim and the reason for the adjusted compensation; and</td>
</tr>
</tbody></table>
<a id="31A-46-302(2)(b)" name="31A-46-302(2)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
provide the reimbursement report:<a id="31A-46-302(2)(b)(i)" name="31A-46-302(2)(b)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
in accordance with the contract between the pharmacy and the pharmacy service entity;</td>
</tr>
</tbody></table>
<a id="31A-46-302(2)(b)(ii)" name="31A-46-302(2)(b)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
in an electronic format that is easily accessible; and</td>
</tr>
</tbody></table>
<a id="31A-46-302(2)(b)(iii)" name="31A-46-302(2)(b)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
within 120 days after the day on which the pharmacy benefit manager receives a report of a sale of a product or service by the pharmacy.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-46-302(3)" name="31A-46-302(3)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(3)</td><td style="width:99%">
A pharmacy service entity shall, upon a pharmacy's request, provide the pharmacy with:
<a id="31A-46-302(3)(a)" name="31A-46-302(3)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
the reasons for any adjustments contained in a reimbursement report; and</td>
</tr>
</tbody></table>
<a id="31A-46-302(3)(b)" name="31A-46-302(3)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
an explanation of the reasons provided in Subsection <a href="#31A-46-302(3)(a)">(3)(a)</a>.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-46-302(4)" name="31A-46-302(4)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(4)</td><td style="width:99%"><a id="31A-46-302(4)(a)" name="31A-46-302(4)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
A pharmacy benefit manager may not prohibit or penalize the disclosure by a pharmacist of:<a id="31A-46-302(4)(a)(i)" name="31A-46-302(4)(a)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
an insured customer's cost share for a covered prescription drug or prescription device;</td>
</tr>
</tbody></table>
<a id="31A-46-302(4)(a)(ii)" name="31A-46-302(4)(a)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
the availability of any therapeutically equivalent alternative medications; or</td>
</tr>
</tbody></table>
<a id="31A-46-302(4)(a)(iii)" name="31A-46-302(4)(a)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
alternative methods of paying for the prescription medication or prescription device, including paying the cash price, that are less expensive than the cost share of the prescription drug.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-46-302(4)(b)" name="31A-46-302(4)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
Penalties that are prohibited under Subsection <a href="#31A-46-302(4)(a)">(4)(a)</a> include increased utilization review, reduced payments, and other financial disincentives.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-46-302(5)" name="31A-46-302(5)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(5)</td><td style="width:99%">
A pharmacy benefit manager may not require an insured customer to pay, for a covered prescription drug or prescription device, more than the lesser of:
<a id="31A-46-302(5)(a)" name="31A-46-302(5)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
the applicable cost share of the prescription drug or prescription device being dispensed;</td>
</tr>
</tbody></table>
<a id="31A-46-302(5)(b)" name="31A-46-302(5)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
the applicable allowable claim amount of the prescription drug or prescription device being dispensed;</td>
</tr>
</tbody></table>
<a id="31A-46-302(5)(c)" name="31A-46-302(5)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
the applicable pharmacy reimbursement of the prescription drug or prescription device being dispensed; or</td>
</tr>
</tbody></table>
<a id="31A-46-302(5)(d)" name="31A-46-302(5)(d)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(d)</td><td style="width:99%">
the retail price of the prescription drug or prescription device without prescription drug coverage.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-46-302(6)" name="31A-46-302(6)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(6)</td><td style="width:99%">
For a contract entered into or renewed on or after May 12, 2020, a pharmacy benefit manager may not engage in direct or indirect remuneration that results in a reduction in total compensation received by a pharmacy from the pharmacy benefit manager for the sale of a drug, device, or other product or service unless the pharmacy benefit manager provides the pharmacy with at least 30 days notice of the direct or indirect remuneration.</td>
</tr>
</tbody></table>
<br>
<br>Amended by Chapter <a href="http://le.utah.gov/UtahCode/ChapterLookup.jsp?chap=198&amp;sess=2020GS">198</a>, 2020 General Session, (Coordination Clause)<br>Amended by Chapter <a href="http://le.utah.gov/UtahCode/ChapterLookup.jsp?chap=198&amp;sess=2020GS">198</a>, 2020 General Session<br>Amended by Chapter <a href="http://le.utah.gov/UtahCode/ChapterLookup.jsp?chap=275&amp;sess=2020GS">275</a>, 2020 General Session<br>
</body></html>